Suresh Veeramani

1.4k citations
23 papers · 1.0k indexed · h-index 15

Suresh Veeramani

23 papers receiving 1.0k citations

Peers

Suresh Veeramani
Comparison fields: 5 of 87
  • Immunology 272
  • Cancer Research 147
  • Pulmonary and Respiratory Medicine 314
  • Oncology 254
  • Radiology, Nuclear Medicine and Imaging 211
Replace Grant Wickman with:
Grant Wickman Canada
Phuong L. Doan United States
Patsy G. Oliver United States
Mikkel G. Terp Denmark
Tsuyoshi Takahashi Japan
Patrick Maier Germany
Brian Higgins United States
Douglas Halverson United States
Jean‐Philip Truman United States
Ismaël Hervé Koumakpayi Canada
Suresh Veeramani relative to Grant Wickman Canada Grant Wickman's profile →
Citations per field
00.5×1.5×2.3×
Grant Wickman · 1×
Citations per year

Countries citing papers authored by Suresh Veeramani

Since Specialization
Citations

This map shows the geographic impact of Suresh Veeramani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Veeramani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Veeramani more than expected).

Fields of papers citing papers by Suresh Veeramani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh Veeramani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Veeramani. The network helps show where Suresh Veeramani may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Suresh Veeramani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suresh Veeramani Line = papers co-authored together Suresh Veeramani links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20244
2 20234
3 202112
4 202011
5 20196
6 20161
7 201481
8 201226
9 201196
10 201042
11 201045
12 2009105
13 200918
14 200827
15 200861
16 2007179
17 200723
18 2006126
19 200551
20 200578

About Suresh Veeramani

Suresh Veeramani is a scholar working on Aging, Immunology and Molecular Biology, having authored 23 papers that have together received 1.0k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (5 papers), Protein Tyrosine Phosphatases (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), RNA and protein synthesis mechanisms (4 papers), RNA Interference and Gene Delivery (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Mitochondrial Function and Pathology (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Immunology (272 citations), Cancer Research (147 citations) and Pulmonary and Respiratory Medicine (314 citations). Suresh Veeramani has collaborated with scholars based in United States, Taiwan and Japan. Frequent co-authors include Ming‐Fong Lin, Ta‐Chun Yuan, George J. Weiner, Fen-Fen Lin, Laura M. Rogers, Siao‐Yi Wang, Surinder K. Batra, Tsukasa Igawa, Stanislav Zelivianski and Dev Karan. Their work appears in journals such as Journal of Biological Chemistry, Blood and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026